Computational methods and opportunities for phosphorylation network medicine

Area of Science:

• Biochemistry
• Cell Biology
• Bioinformatics

Background:

• Protein phosphorylation is a key post-translational modification regulating cell signaling.
• Cancer research increasingly targets complex signaling networks due to their complexity and redundancy.
• Protein kinases are major drug targets in cancer therapy, with inhibitors widely used clinically.

Purpose of the Study:

• To review the current state of phosphoproteomics for identifying and quantifying protein phosphorylation.
• To discuss platform characteristics, database resources, and computational tools in phosphoproteomics.
• To highlight the connection between phosphoproteomics advancements and cancer therapeutics.

Main Methods:

• Review of high-throughput proteomics platforms, particularly mass-spectrometry (MS)-based methods.
• Analysis of existing public databases and computational tools for phosphoproteomics data.
• Examination of methods for inferring phosphorylation networks.

Main Results:

• Phosphoproteomics, driven by MS and high-throughput platforms, provides high-dimensional data essential for cancer research.
• Numerous database resources and computational tools are available to support phosphoproteomics analysis.
• Inference of phosphorylation networks is advancing, linking molecular insights to therapeutic strategies.

Conclusions:

• Phosphoproteomics advancements are critical for understanding cell signaling and developing targeted cancer therapies.
• The integration of phosphoproteomics data, computational tools, and network inference offers significant opportunities for therapeutic development.
• Future research in bioinformatics and biostatistics is essential to address limitations and leverage emerging technologies in phosphoproteomics.